Skip to main content
Top
Published in: BMC Neurology 1/2013

Open Access 01-12-2013 | Research article

Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series

Authors: Álvaro Cobo Calvo, M Alba Mañé Martínez, Agustí Alentorn-Palau, Jordi Bruna Escuer, Lucía Romero Pinel, Sergio Martínez-Yélamos

Published in: BMC Neurology | Issue 1/2013

Login to get access

Abstract

Background

In 2002, the Transverse Myelitis Consortium Working Group (TMCWG) proposed the diagnostic criteria for idiopathic acute transverse myelitis (IATM) to delimit and unify this group of patients. This study aimed to describe the conversion rate to multiple sclerosis (MS) and variables associated with conversion, and to analyze functional outcome and prognostic factors associated with functional recovery in patients who fulfilled the current TMCWG criteria for definite and possible IATM.

Methods

Eighty-seven patients diagnosed with IATM between 1989 and 2011 were retrospectively reviewed. Two patients with positive neuromyelitis optica IgG serum antibodies were excluded. Epidemiological, clinical, laboratory, magnetic resonance imaging (MRI) data and outcome of 85 patients were analyzed.

Results

Eleven (13%) patients converted to MS after a median follow-up of 2.9 years (interquartile range 1.0-4.8). Early-age onset of symptoms was related to conversion to MS. Only 9.4% of patients with IATM were unable to walk unassisted at the end of follow-up. Urinary sphincter dysfunction (odds ratio [OR] 3.37, 95% confidence interval [CI] 1.04-10.92) and longitudinally extensive transverse myelitis (LETM) on MRI (OR 12.34, 95% CI 3.38-45.00) were associated with a poorer outcome (Rankin ≥ 2).

Conclusions

At least 13% of patients who fulfill the TMCWG criteria for definite and possible IATM will convert to MS. Functional recovery in IATM is poorer in patients with urinary sphincter dysfunction at admission or LETM on MRI.
Appendix
Available only for authorised users
Literature
1.
go back to reference Transverse Myelitis Consortium Working Group: Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002, 59: 499-505.CrossRef Transverse Myelitis Consortium Working Group: Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002, 59: 499-505.CrossRef
2.
go back to reference Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004, 364: 2106-2112. 10.1016/S0140-6736(04)17551-X.CrossRefPubMed Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004, 364: 2106-2112. 10.1016/S0140-6736(04)17551-X.CrossRefPubMed
3.
go back to reference Bruna J, Martínez-Yélamos S, Martínez-Yélamos A, Rubio F, Arbizu T: Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler. 2006, 12: 169-173. 10.1191/135248506ms1260oa.CrossRefPubMed Bruna J, Martínez-Yélamos S, Martínez-Yélamos A, Rubio F, Arbizu T: Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler. 2006, 12: 169-173. 10.1191/135248506ms1260oa.CrossRefPubMed
4.
go back to reference Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F: Revised criteria for neuromyelitis optica (NMO). J Neurol. 2007, 254: 1233-1237. 10.1007/s00415-007-0509-8.CrossRefPubMed Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F: Revised criteria for neuromyelitis optica (NMO). J Neurol. 2007, 254: 1233-1237. 10.1007/s00415-007-0509-8.CrossRefPubMed
5.
go back to reference Whingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology. 2007, 66: 1485-1489.CrossRef Whingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology. 2007, 66: 1485-1489.CrossRef
6.
go back to reference Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983, 13: 227-231. 10.1002/ana.410130302.CrossRefPubMed Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983, 13: 227-231. 10.1002/ana.410130302.CrossRefPubMed
7.
go back to reference Polman CH, Reingold SC, Banwel B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011, 69: 292-302. 10.1002/ana.22366.CrossRefPubMedPubMedCentral Polman CH, Reingold SC, Banwel B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011, 69: 292-302. 10.1002/ana.22366.CrossRefPubMedPubMedCentral
8.
go back to reference Brun JP: Reliability of the modified Rankin scale. Stroke. 1992, 23: 438- Brun JP: Reliability of the modified Rankin scale. Stroke. 1992, 23: 438-
9.
go back to reference Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG: The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6: 805-815. 10.1016/S1474-4422(07)70216-8.CrossRefPubMed Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG: The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6: 805-815. 10.1016/S1474-4422(07)70216-8.CrossRefPubMed
10.
go back to reference Collongues N, Marignier R, Zéphir H, Papeix C, Blanc F, Ritleng C, Tchikviladzé M, Outteryck O, Vukusic S, Fleury M, Fontaine B, Brassat D, Clanet M, Milh M, Pelletier J, Audoin B, Ruet A, Lebrun-Frenay C, Thouvenot E, Camu W, Debouverie M, Créange A, Moreau T, Labauge P, Castelnovo G, Edan G, Le Page E, Defer G, Barroso B, Heinzlef O, et al: Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology. 2010, 74: 737-742.CrossRef Collongues N, Marignier R, Zéphir H, Papeix C, Blanc F, Ritleng C, Tchikviladzé M, Outteryck O, Vukusic S, Fleury M, Fontaine B, Brassat D, Clanet M, Milh M, Pelletier J, Audoin B, Ruet A, Lebrun-Frenay C, Thouvenot E, Camu W, Debouverie M, Créange A, Moreau T, Labauge P, Castelnovo G, Edan G, Le Page E, Defer G, Barroso B, Heinzlef O, et al: Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology. 2010, 74: 737-742.CrossRef
11.
go back to reference Kitley JL, Leite MI, George JS, Palace JA: The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler. 2012, 18: 271-285. 10.1177/1352458511406165.CrossRefPubMed Kitley JL, Leite MI, George JS, Palace JA: The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler. 2012, 18: 271-285. 10.1177/1352458511406165.CrossRefPubMed
12.
go back to reference Pawate S, Sriram S: Isolated longitudinal myelitis: a report of six cases. Spinal Cord. 2009, 47: 257-261. 10.1038/sc.2008.99.CrossRefPubMed Pawate S, Sriram S: Isolated longitudinal myelitis: a report of six cases. Spinal Cord. 2009, 47: 257-261. 10.1038/sc.2008.99.CrossRefPubMed
13.
go back to reference Alvarenga MP, Thuler LC, Neto SP, Vasconcelos CC, Camargo SG, Alvarenga MP, Papais-Alvarenga RM: The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro. J Neurol. 2010, 257: 992-998. 10.1007/s00415-009-5450-6.CrossRefPubMed Alvarenga MP, Thuler LC, Neto SP, Vasconcelos CC, Camargo SG, Alvarenga MP, Papais-Alvarenga RM: The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro. J Neurol. 2010, 257: 992-998. 10.1007/s00415-009-5450-6.CrossRefPubMed
14.
go back to reference De Seze J, Lanctin C, Lebrun C, Malikova I, Papeix C, Wiertlewski S, Pelletier J, Gout O, Clerc C, Moreau C, Defer G, Edan G, Dubas F, Vermersch P: Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology. 2005, 65: 1950-1953. 10.1212/01.wnl.0000188896.48308.26.CrossRefPubMed De Seze J, Lanctin C, Lebrun C, Malikova I, Papeix C, Wiertlewski S, Pelletier J, Gout O, Clerc C, Moreau C, Defer G, Edan G, Dubas F, Vermersch P: Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology. 2005, 65: 1950-1953. 10.1212/01.wnl.0000188896.48308.26.CrossRefPubMed
15.
go back to reference Young J, Quinn S, Hurrell M, Taylor B: Clinically isolated acute transverse myelitis: prognostic features and incidence. Mult Scler. 2009, 15: 1295-1302. 10.1177/1352458509345906.CrossRefPubMed Young J, Quinn S, Hurrell M, Taylor B: Clinically isolated acute transverse myelitis: prognostic features and incidence. Mult Scler. 2009, 15: 1295-1302. 10.1177/1352458509345906.CrossRefPubMed
16.
go back to reference Scott TF, Frohman EM, De Seze J, Gronseth GS, Weinshenker BG, J: Evidence-based guideline: clinical evaluation and treatment of transverse myelitis. Neurology. 2011, 77: 2128-2134. 10.1212/WNL.0b013e31823dc535.CrossRefPubMed Scott TF, Frohman EM, De Seze J, Gronseth GS, Weinshenker BG, J: Evidence-based guideline: clinical evaluation and treatment of transverse myelitis. Neurology. 2011, 77: 2128-2134. 10.1212/WNL.0b013e31823dc535.CrossRefPubMed
17.
go back to reference Sepúlveda M, Blanco Y, Rovira A, Rio J, Mendibe M, Llufriu S, Gabilondo I, Villoslada P, Castilló J, Corral J, Ayuso T, Iñiguez C, Santos S, Guijarro C, Ramió-Torrentà L, Sempere AP, Olascoaga J, Graus F, Montalban X, Saiz A: Analysis of prognostic factors associated with longitudinally extensive transverse myelitis. Mult Scler. 2013, 19: 742-748. 10.1177/1352458512461968.CrossRefPubMed Sepúlveda M, Blanco Y, Rovira A, Rio J, Mendibe M, Llufriu S, Gabilondo I, Villoslada P, Castilló J, Corral J, Ayuso T, Iñiguez C, Santos S, Guijarro C, Ramió-Torrentà L, Sempere AP, Olascoaga J, Graus F, Montalban X, Saiz A: Analysis of prognostic factors associated with longitudinally extensive transverse myelitis. Mult Scler. 2013, 19: 742-748. 10.1177/1352458512461968.CrossRefPubMed
18.
go back to reference Chaves M, Rojas JI, Patrucco L, Cristiano E: Acute transverse myelitis in Buenos aires, Argentina. A retrospective cohort study of 8 years follow up. Neurologia. 2012, 27: 348-353. 10.1016/j.nrl.2011.09.014.CrossRefPubMed Chaves M, Rojas JI, Patrucco L, Cristiano E: Acute transverse myelitis in Buenos aires, Argentina. A retrospective cohort study of 8 years follow up. Neurologia. 2012, 27: 348-353. 10.1016/j.nrl.2011.09.014.CrossRefPubMed
19.
go back to reference Misra UK, Kalita J, Kumar S: A clinical, MRI and neurophysiological study of acute transverse myelitis. J Neurol Sci. 1996, 138: 150-156. 10.1016/0022-510X(95)00353-4.CrossRefPubMed Misra UK, Kalita J, Kumar S: A clinical, MRI and neurophysiological study of acute transverse myelitis. J Neurol Sci. 1996, 138: 150-156. 10.1016/0022-510X(95)00353-4.CrossRefPubMed
20.
go back to reference Al Deeb SM, Yaqub BA, Bruyn GW, Biary NM: Acute transverse myelitis. A localized form of postinfectious encephalomyelitis. Brain. 1997, 120: 1115-1122. 10.1093/brain/120.7.1115.CrossRefPubMed Al Deeb SM, Yaqub BA, Bruyn GW, Biary NM: Acute transverse myelitis. A localized form of postinfectious encephalomyelitis. Brain. 1997, 120: 1115-1122. 10.1093/brain/120.7.1115.CrossRefPubMed
21.
go back to reference Christensen PB, Wermuth L, Hinge HH, Bomers K: Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand. 1990, 8: 431-435. Christensen PB, Wermuth L, Hinge HH, Bomers K: Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand. 1990, 8: 431-435.
22.
go back to reference Ropper AH, Poskanzer DC: The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol. 1978, 4: 51-59. 10.1002/ana.410040110.CrossRefPubMed Ropper AH, Poskanzer DC: The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol. 1978, 4: 51-59. 10.1002/ana.410040110.CrossRefPubMed
23.
go back to reference Li R, Qiu W, Lu Z, Dai Y, Wu A, Long Y, Wang Y, Bao J, Hu X: Acute transverse myelitis in demyelinating diseases among the Chinese. J Neurol. 2011, 258: 2206-2213. 10.1007/s00415-011-6093-y.CrossRefPubMed Li R, Qiu W, Lu Z, Dai Y, Wu A, Long Y, Wang Y, Bao J, Hu X: Acute transverse myelitis in demyelinating diseases among the Chinese. J Neurol. 2011, 258: 2206-2213. 10.1007/s00415-011-6093-y.CrossRefPubMed
24.
go back to reference Gajofatto A, Monaco S, Fiorini M, Zanusso G, Vedovello M, Rossi F, Turatti M, Benedetti MD: Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. Arch Neurol. 2010, 67: 724-730. 10.1001/archneurol.2010.107.CrossRefPubMed Gajofatto A, Monaco S, Fiorini M, Zanusso G, Vedovello M, Rossi F, Turatti M, Benedetti MD: Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. Arch Neurol. 2010, 67: 724-730. 10.1001/archneurol.2010.107.CrossRefPubMed
25.
go back to reference Scott TF, Kassab SL, Singh S: Acute transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler. 2005, 11: 373-377. 10.1191/1352458505ms1194oa.CrossRefPubMed Scott TF, Kassab SL, Singh S: Acute transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler. 2005, 11: 373-377. 10.1191/1352458505ms1194oa.CrossRefPubMed
26.
go back to reference Tintoré M, Rovira A, Río J, Tur C, Pelayo R, Nos C, Téllez N, Perkal H, Comabella M, Sastre-Garriga J, Montalban X: Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?. Neurology. 2008, 70: 1079-1083.CrossRefPubMed Tintoré M, Rovira A, Río J, Tur C, Pelayo R, Nos C, Téllez N, Perkal H, Comabella M, Sastre-Garriga J, Montalban X: Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?. Neurology. 2008, 70: 1079-1083.CrossRefPubMed
27.
go back to reference Perumal J, Zabad R, Caon C, MacKenzie M, Tselis A, Bao F, Latif Z, Zak I, Lisak R, Khan O: Acute transverse myelitis with normal brain MRI: long-term risk of MS. J Neurol. 2008, 255: 89-93. 10.1007/s00415-007-0686-5.CrossRefPubMed Perumal J, Zabad R, Caon C, MacKenzie M, Tselis A, Bao F, Latif Z, Zak I, Lisak R, Khan O: Acute transverse myelitis with normal brain MRI: long-term risk of MS. J Neurol. 2008, 255: 89-93. 10.1007/s00415-007-0686-5.CrossRefPubMed
28.
go back to reference Ruet A, Deloire MS, Ouallet JC, Molinier S, Brochet B: Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome. Mult Scler. 2011, 17: 312-318. 10.1177/1352458510386999.CrossRefPubMed Ruet A, Deloire MS, Ouallet JC, Molinier S, Brochet B: Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome. Mult Scler. 2011, 17: 312-318. 10.1177/1352458510386999.CrossRefPubMed
29.
go back to reference Cordonnier C, De Seze J, Breteau G, Ferriby D, Michelin E, Stojkovic T, Pruvo JP, Vermersch P: Prospective study of patients presenting with acute partial transverse myelopathy. J Neurol. 2003, 250: 1447-1452. 10.1007/s00415-003-0242-x.CrossRefPubMed Cordonnier C, De Seze J, Breteau G, Ferriby D, Michelin E, Stojkovic T, Pruvo JP, Vermersch P: Prospective study of patients presenting with acute partial transverse myelopathy. J Neurol. 2003, 250: 1447-1452. 10.1007/s00415-003-0242-x.CrossRefPubMed
30.
go back to reference Jarius S, Ruprecht K, Wildermann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, et al: Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinmflammation. 2012, 9: 14-10.1186/1742-2094-9-14. Jarius S, Ruprecht K, Wildermann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, et al: Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinmflammation. 2012, 9: 14-10.1186/1742-2094-9-14.
31.
go back to reference Kitley J, Leite MI, Nakashima I, Waters P, McNeillis B, Brown R, Takai Y, Takahashi T, Misu T, Elsone L, Woodhall M, George J, Boggild M, Vincent A, Jacob A, Fujihara K, Palace J: Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain. 2012, 135: 1834-1849. 10.1093/brain/aws109.CrossRefPubMed Kitley J, Leite MI, Nakashima I, Waters P, McNeillis B, Brown R, Takai Y, Takahashi T, Misu T, Elsone L, Woodhall M, George J, Boggild M, Vincent A, Jacob A, Fujihara K, Palace J: Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain. 2012, 135: 1834-1849. 10.1093/brain/aws109.CrossRefPubMed
Metadata
Title
Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series
Authors
Álvaro Cobo Calvo
M Alba Mañé Martínez
Agustí Alentorn-Palau
Jordi Bruna Escuer
Lucía Romero Pinel
Sergio Martínez-Yélamos
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2013
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-13-135

Other articles of this Issue 1/2013

BMC Neurology 1/2013 Go to the issue